# Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine

> **NCT02704962** · PHASE4 · COMPLETED · sponsor: **Kaohsiung Kai-Suan Psychiatric Hospital** · enrollment: 94 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** full-dose olanzapine

## Key facts

- **NCT ID:** NCT02704962
- **Lead sponsor:** Kaohsiung Kai-Suan Psychiatric Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2016-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02704962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02704962, "Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02704962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*